The American Amnion Association is proud to release a compelling new episode of our podcast series—this time featuring Jerry Pascucci, President of the Board and one of the medtech industry’s most forward-thinking leaders.
In Episode 2: “Amniotic Tissue, Innovation & the Road to Standard of Care”, Jerry joins Vice President Theresa Hong for a rich and insightful conversation about the evolving landscape of birth tissue-derived medical technologies, the regulatory challenges and opportunities facing the field, and the powerful clinical outcomes being driven by amniotic membrane use.
With over a decade of leadership in the medical technology sector, Jerry brings invaluable experience guiding startups and scaling innovation across surgical specialties. In this episode, he shares:
His journey from orthopedic trauma rep to amnion-focused medtech executive
The history and healing power of amniotic membrane, dating back to 1915
Why surgical applications of amnion are gaining traction in GYN, colorectal, urology, thoracic, and cardiothoracic procedures
Insights into off-label use, FDA pathways, and the future of regulatory reform
The role of real-world evidence in proving amnion’s efficacy—and how clinical trials are paving the way for standard of care recognition
Honest reflections on industry challenges, reimbursement hurdles, and the ethics of putting patient outcomes over profits
As Jerry says, “We’re not just talking about what amnion does—we’re asking how it does it, and why. And that’s where the future of regenerative healthcare begins.”
Whether you’re a clinician, a policy leader, or someone curious about the next frontier in healing, this episode is a must-listen.
Listen Now and Subscribe to stay updated on cutting-edge conversations in regenerative medicine.
#AmnioticMedicine #RegenerativeHealth #SurgicalInnovation #Amnion #HealthcareReform #AmericanAmnionAssociation